1. Adriamycin nephropathy: a failure of endothelial progenitor cell-induced repair. Yasuda K, Park HC, Ratliff B, Addabbo F, Hatzopoulos AK, Chander P, Goligorsky MS (2010) Am J Pathol 176(4): 1685-95
    › Primary publication · 20167859 (PubMed) · PMC2843460 (PubMed Central)
  2. The FunGenES database: a genomics resource for mouse embryonic stem cell differentiation. Schulz H, Kolde R, Adler P, Aksoy I, Anastassiadis K, Bader M, Billon N, Boeuf H, Bourillot PY, Buchholz F, Dani C, Doss MX, Forrester L, Gitton M, Henrique D, Hescheler J, Himmelbauer H, Hübner N, Karantzali E, Kretsovali A, Lubitz S, Pradier L, Rai M, Reimand J, Rolletschek A, Sachinidis A, Savatier P, Stewart F, Storm MP, Trouillas M, Vilo J, Welham MJ, Winkler J, Wobus AM, Hatzopoulos AK, Functional Genomics in Embryonic Stem Cells Consortium (2009) PLoS One 4(9): e6804
    › Primary publication · 19727443 (PubMed) · PMC2731164 (PubMed Central)
  3. T17b murine embryonal endothelial progenitor cells can be induced towards both proliferation and differentiation in a fibrin matrix. Bleiziffer O, Horch RE, Hammon M, Arkudas A, Naschberger E, Rath S, Pryymachuk G, Beier JP, Hatzopoulos AK, Stürzl M, Kneser U (2009) J Cell Mol Med 13(5): 926-35
    › Primary publication · 19538255 (PubMed) · PMC2827195 (PubMed Central)
  4. Stem cell therapy for cardiac repair: benefits and barriers. Joggerst SJ, Hatzopoulos AK (2009) Expert Rev Mol Med : e20
    › Primary publication · 19586557 (PubMed)
  5. Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Traverse JH, Henry TD, Vaughan DE, Vaughn DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Piller LB, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moye' LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN) (2009) Am Heart J 158(3): 356-63
    › Primary publication · 19699857 (PubMed) · PMC2784639 (PubMed Central)
  6. Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Boudoulas KD, Hatzopoulos AK (2009) Dis Model Mech 2(7-8): 344-58
    › Primary publication · 19553696 (PubMed) · PMC2707103 (PubMed Central)
  7. Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Hinkel R, El-Aouni C, Olson T, Horstkotte J, Mayer S, Müller S, Willhauck M, Spitzweg C, Gildehaus FJ, Münzing W, Hannappel E, Bock-Marquette I, DiMaio JM, Hatzopoulos AK, Boekstegers P, Kupatt C (2008) Circulation 117(17): 2232-40
    › Primary publication · 18427126 (PubMed) · PMC2672916 (PubMed Central)
  8. Proteins of the secretory pathway govern virus productivity during lytic gammaherpesvirus infection. Mages J, Freimüller K, Lang R, Hatzopoulos AK, Guggemoos S, Koszinowski UH, Adler H (2008) J Cell Mol Med 12(5B): 1974-89
    › Primary publication · 18194452 (PubMed) · PMC2673020 (PubMed Central)
  9. Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis. Karantzali E, Schulz H, Hummel O, Hubner N, Hatzopoulos A, Kretsovali A (2008) Genome Biol 9(4): R65
    › Primary publication · 18394158 (PubMed) · PMC2643936 (PubMed Central)
  10. Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke. Beck H, Semisch M, Culmsee C, Plesnila N, Hatzopoulos AK (2008) Am J Pathol 173(1): 77-92
    › Primary publication · 18556777 (PubMed) · PMC2438287 (PubMed Central)